Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -13586.02% is 94% above its 1-year average of -216185.04%, near the high end of its 1-year range (-762166.37%–-4495.59%).
95.17% above its 12-month average of -281074.42%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2019 (2019-12-31): -4495.59%.
EBITDA MARGIN
-13586.02%
EBITDA MARGIN AVG TTM
-281074.42%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+95.17%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Quantum BioPharma Ltd.
Market Cap
$21.05M
EBITDA Margin
-13586.02%
TTM Avg
-281074.42%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$20.16M
EBITDA Margin
-168.97%
TTM Avg
-358.59%
3Y Avg
-358.59%
5Y Avg
-358.59%
Market Cap
$22.22M
EBITDA Margin
-7.62%
TTM Avg
-5.66%
3Y Avg
-2.78%
5Y Avg
-31.67%
Market Cap
$18.80M
EBITDA Margin
-12.76%
TTM Avg
-13.93%
3Y Avg
-43.67%
5Y Avg
-34.75%
Market Cap
$18.67M
EBITDA Margin
-779.07%
TTM Avg
-389.93%
3Y Avg
-389.93%
5Y Avg
-2320.55%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum BioPharma Ltd. (QNTM) | $21.05M | -13586.02% | -281074.42% | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $21.93M | N/A | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.16M | -168.97% | -358.59% | -358.59% | -358.59% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.22M | -7.62% | -5.66% | -2.78% | -31.67% |
| LeonaBio, Inc. (LONA)vs › | $22.36M | N/A | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $22.85M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.14M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $18.80M | -12.76% | -13.93% | -43.67% | -34.75% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.67M | -779.07% | -389.93% | -389.93% | -2320.55% |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.84M | -99.97% | -151.18% | -217.30% | -694.48% |
Gross Margin
0.0%
EBITDA Margin
-13586.0%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2019-12-31 | -4495.59% |
| 2019-09-30 | -76561.31% |
| 2018-12-31 | -762166.37% |
| 2018-09-30 | -21516.90% |
